American Lung Association

Idiopathic pulmonary fibrosis (IPF) is a severe disease that causes scar tissue to form in the lungs. Current therapies do not significantly increase patient survival, underscoring the urgent need for innovative strategies to slow or reverse lung fibrosis. IPF is the result of gradual damage to airway epithelial cells found in the lungs. Restoring the ability of these cells to regenerate could help reduce the disease. We will test the interactions between epithelial cells and immune/inflammatory